SCHEMBL657210

SCHEMBL657210

O=C(O)CC(CC(=O)OC(=O)CC(CC(=O)O)c1ccccc1Br)c1ccccc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 1/20 0.41
GABBR1 Q9UBS5 1/20 0.41
CYP26A1 O43174 2/20 0.40
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 2/20 0.39
POLB P06746 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
MIF P14174 1/20 0.36
CYP1A2 P05177 1/20 0.35
TSHR P16473 1/20 0.35
MAPT P10636 1/20 0.35
CTSG P08311 1/20 0.35
CTRB1 P17538 1/20 0.35
CPA1 P15085 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30437060 0.90 GABBR2 (0.48) GABBR2GABBR1CYP26A1CYP2C9CYP2C19
SCHEMBL658742 0.90 GABBR2 (0.48) GABBR2GABBR1CYP26A1CYP2C9CYP2C19
SCHEMBL657343 0.81 CTSA (0.42) GABBR2GABBR1HTTPOLBNPSR1
SCHEMBL18151385 0.79 POLB (0.63) GABBR2GABBR1HTTPOLBNPSR1
SCHEMBL657068 0.78 HPGD (0.54) GABBR2GABBR1CYP2C9CYP2C19HTT
SCHEMBL9541616 0.78 GABBR2 (0.61) GABBR2GABBR1HTTPOLBNPSR1
SCHEMBL657290 0.78 GABBR2 (0.61) GABBR2GABBR1HTTPOLBNPSR1
SCHEMBL23209997 0.77 TSHR (0.46) CYP2C9CYP2C19HTTIDO1TDO2
SCHEMBL29619719 0.77 TSHR (0.46) CYP2C9CYP2C19HTTIDO1TDO2
SCHEMBL7763294 0.75 CYP1A2 (0.46) GABBR2GABBR1CYP26A1HTTFNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB GABBR2 4480/4885GABBR1 4561/4885CYP26A1 4700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.